Frequent epigenetic inactivation of RASSF2 in thyroid cancer and functional consequences
about
RASSF tumor suppressor gene family: biological functions and regulationIdentification of differentially methylated genes in the malignant transformation of ovarian endometriosis.Promoter methylation status of Ras-association domain family members in pheochromocytoma.The SARAH Domain of RASSF1A and Its Tumor Suppressor FunctionThe RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma.Differential involvement of RASSF2 hypermethylation in breast cancer subtypes and their prognosis.RASSF8 regulates progression of cutaneous melanoma through nuclear factor-κb.Aberrant Promoter Hypermethylation of RASSF Family Members in Merkel Cell Carcinoma.Functional single nucleotide polymorphisms of the RASSF3 gene and susceptibility to squamous cell carcinoma of the head and neck.Genetics and epigenetics of sporadic thyroid cancer.The emergence of the mitochondrial genome as a partial regulator of nuclear function is providing new insights into the genetic mechanisms underlying age-related complex disease.Analysis of Liver Tumor-Prone Mouse Models of the Hippo Kinase Scaffold Proteins RASSF1A and SAV1.Principles of K-Ras effector organization and the role of oncogenic K-Ras in cancer initiation through G1 cell cycle deregulation.RASSF2 methylation is a strong prognostic marker in younger age patients with Ewing sarcomaEpigenetic down regulation of RASSF10 and its possible clinical implication in prostate carcinoma.Proteomics Analysis Reveals Novel RASSF2 Interaction Partners.Aberrant hypermethylation of RASSF2 in tumors and peripheral blood DNA as a biomarker for malignant progression and poor prognosis of esophageal squamous cell carcinoma.Prognostic importance of RASSF2 expression in patients with gastric cancer who had undergone radical gastrectomy.RASSF6 downregulation promotes the epithelial-mesenchymal transition and predicts poor prognosis in colorectal cancer.Ectopic expression of RASSF2 and its prognostic role for gastric adenocarcinoma patients.Loss of RASSF2 Enhances Tumorigencity of Lung Cancer Cells and Confers Resistance to Chemotherapy.The tumor suppressor RASSF10 is upregulated upon contact inhibition and frequently epigenetically silenced in cancer.From evolutionary bystander to master manipulator: the emerging roles for the mitochondrial genome as a modulator of nuclear gene expression.Impact of Natural Compounds on DNA Methylation Levels of the Tumor Suppressor Gene RASSF1A in Cancer.The tumor suppressor RASSF1A induces the YAP1 target gene ANKRD1 that is epigenetically inactivated in human cancers and inhibits tumor growth.Decreased expression and frequent promoter hypermethylation of RASSF2 and RASSF6 correlate with malignant progression and poor prognosis of gastric cardia adenocarcinoma.MST2-RASSF protein-protein interactions through SARAH domains.RASSF2 hypermethylation is present and related to shorter survival in squamous cervical cancer.
P2860
0effd4ef5b958d07c516884bb788276c6898d7b11f9cafb3d0cf6c3dbc44075512463b5047b6befd29a35cd54e72611248537d010605166e96238f48a34c3d7e627bd5a9f12b1e8276bac4d6b5a636c3c46265d02c8eae705baa962aafe6d1d9e1e770cdcdac706c876dd6b2308a354c74ac9ae251d1579bd89e4ee1482fa232f549782eb25eaf8de9237509eaa0734b1d15faae224d9ce9fb5021ef5f624c5efda8a771fd7d157ffbd8d5042114df7494931ebd
P248
Q26866080-0864B0B2-A550-4FBD-B867-571E5A3A8AA9Q33927116-711B17CD-837B-472A-982A-5B19D6BB44DDQ35099523-AB86A4D7-0B91-4AB2-9BE4-F4509CB86457Q35915463-13D43DFC-27CC-4C43-ABF6-1624747405F5Q36383883-73937767-81F6-404F-8984-BEBBB3A193C6Q36414347-BA3EEA43-53D7-4CF5-9DA4-6BC9044C17A6Q36557527-AA1E5D6C-3384-42B9-881A-94ADAC5CEF9FQ37420605-C0DF1C25-6DD8-453D-B759-1233C93C65D6Q37625248-E71A497C-63F0-4B81-95DA-09633D073DA5Q38128097-A95BD8B6-55B5-4FAC-89B4-4B6AE4838029Q38168700-63524B1C-1E1B-44A4-A82D-A78A223691B4Q38293195-3D47814C-3216-4A67-B7E7-FECB9A04E2D6Q38614956-EC7599A9-5752-4425-94DF-65F8FB49663AQ39120311-684C14AA-4B0C-4C03-A377-3555DAFE0CBEQ39380271-9192226C-2E25-4983-B2C0-0C28FAB42CC3Q39583823-C5433DC9-3003-4A37-AFEE-79AD693662D2Q41202043-0FE93053-AEF7-49DA-84F4-60B0DCD58453Q41231684-B23F465F-DA08-4B84-BF00-4B603E3BB21DQ41549318-97045DD2-D315-4E23-9B2A-ABD298D3783BQ41878340-1D7085DB-AC11-49F8-AFBD-552FB4624216Q42184843-486DA602-F3E4-43DA-A15A-ED1A9B83CEC6Q42239802-E05BD074-3F21-4D9C-9A51-37FEA8ECB95AQ42905858-4BC0A805-C96A-4484-B0FA-4681C5A17CD0Q45814721-A00FB2D1-8A0A-4B98-A935-670A2FA6F925Q47116225-18FB5605-6199-4D66-B471-72C45C7A7DB4Q53315728-773B667E-73EC-448F-88C0-2DC36464EFB0Q53498705-9A21CFFA-CC67-4664-9A25-130637E3AEC6Q54266041-52C580A3-27B1-49B5-8DBD-750B67893EE4
P2860
Frequent epigenetic inactivation of RASSF2 in thyroid cancer and functional consequences
description
2010 nî lūn-bûn
@nan
2010 թուականին հրատարակուած գիտական յօդուած
@hyw
2010 թվականին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Frequent epigenetic inactivation of RASSF2 in thyroid cancer and functional consequences
@ast
Frequent epigenetic inactivation of RASSF2 in thyroid cancer and functional consequences
@en
Frequent epigenetic inactivation of RASSF2 in thyroid cancer and functional consequences
@en-gb
Frequent epigenetic inactivation of RASSF2 in thyroid cancer and functional consequences
@nl
type
label
Frequent epigenetic inactivation of RASSF2 in thyroid cancer and functional consequences
@ast
Frequent epigenetic inactivation of RASSF2 in thyroid cancer and functional consequences
@en
Frequent epigenetic inactivation of RASSF2 in thyroid cancer and functional consequences
@en-gb
Frequent epigenetic inactivation of RASSF2 in thyroid cancer and functional consequences
@nl
prefLabel
Frequent epigenetic inactivation of RASSF2 in thyroid cancer and functional consequences
@ast
Frequent epigenetic inactivation of RASSF2 in thyroid cancer and functional consequences
@en
Frequent epigenetic inactivation of RASSF2 in thyroid cancer and functional consequences
@en-gb
Frequent epigenetic inactivation of RASSF2 in thyroid cancer and functional consequences
@nl
P2093
P2860
P356
P1433
P1476
Frequent epigenetic inactivation of RASSF2 in thyroid cancer and functional consequences
@en
P2093
Antje M Richter
Cornelia Lange
Juliane Hornung
Katrin Steinmann
Reinhard H Dammann
Undraga Schagdarsurengin
P2860
P2888
P356
10.1186/1476-4598-9-264
P407
P577
2010-01-01T00:00:00Z
P5875
P6179
1019160022